BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3089289)

  • 1. Appearance of the arachidonic acid metabolic pathway in human promyelocytic leukemia (HL-60) cells during monocytic differentiation: enhancement of thromboxane synthesis by 1 alpha,25-dihydroxyvitamin D-3.
    Honda A; Morita I; Murota S; Mori Y
    Biochim Biophys Acta; 1986 Jul; 877(3):423-32. PubMed ID: 3089289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane formation from arachidonic acid and prostaglandin H2 in rabbit spleen.
    Hidaka T; Ueta T; Ogura R
    J Biochem; 1983 Feb; 93(2):367-73. PubMed ID: 6404897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid metabolism by nuclei of a retinoic acid--or vitamin D3-differentiated human leukemia cell line HL-60.
    Matsumoto K; Morita I; Murota S
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jul; 51(1):51-5. PubMed ID: 7938099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin production by human promyelocytic leukemia (HL-60) cells.
    Sanduja SK; Trial J; Hall ER
    Biomed Biochim Acta; 1988; 47(4-5):383-93. PubMed ID: 2907294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic acid metabolism by a vitamin D3-differentiated human leukemic cell line.
    Stenson WF; Teitelbaum SL; Bar-Shavit Z
    J Bone Miner Res; 1988 Oct; 3(5):561-71. PubMed ID: 2848399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cyclo-oxygenase synthesis in human promyelocytic leukaemia (HL-60) cells during monocytic or granulocytic differentiation.
    Honda A; Raz A; Needleman P
    Biochem J; 1990 Nov; 272(1):259-62. PubMed ID: 2176083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of thromboxane synthesis by novel 26,27-dialkyl analogues of 1 alpha,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells.
    Honda A; Mori Y; Ikekawa N; Raz A
    Eur J Pharmacol; 1992 Dec; 229(2-3):217-22. PubMed ID: 1337046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2, prostaglandin E1 and thromboxane B2 release from human monocytes treated with C3b or bacterial lipopolysaccharide.
    Nichols FC; Schenkein HA; Rutherford RB
    Biochim Biophys Acta; 1987 Feb; 927(2):149-57. PubMed ID: 3101743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.
    Ingerman-Wojenski C; Silver MJ; Smith JB; Macarak E
    J Clin Invest; 1981 May; 67(5):1292-6. PubMed ID: 7014633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thromboxane B2 biosynthesis in platelets.
    Kawaguchi H; Ishibashi T; Imai Y
    Lipids; 1982 Sep; 17(9):577-84. PubMed ID: 6815401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrolein: a potent modulator of lung macrophage arachidonic acid metabolism.
    Grundfest CC; Chang J; Newcombe D
    Biochim Biophys Acta; 1982 Oct; 713(1):149-59. PubMed ID: 6814492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotine on eicosanoid synthesis of differentiating human promyelocytic leukemia cells.
    Goerig M; Habenicht AJ
    Klin Wochenschr; 1988; 66 Suppl 11():117-9. PubMed ID: 3141674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
    Mayeux PR; Kadowitz PJ; McNamara DB
    Biochim Biophys Acta; 1989 Mar; 1011(1):18-24. PubMed ID: 2493809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G; Smith GM
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line.
    Ball ED; Howell AL; Shen L
    Exp Hematol; 1986 Dec; 14(11):998-1005. PubMed ID: 3096754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
    Rybicki JP; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Mar; 751(1):66-73. PubMed ID: 6830832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.